Watch Ticker

NLS Pharmaceutics Ltd. Ordinary Shares

Go to NLS Pharmaceutics Ltd. Ordinary Shares Website

$1.89

0.00 (-0.11%)

Live

Previous Close

$1.887

Day Range

$1.81 - $2

Previous Day Range

$1.79 - $1.94

Market Cap

$8.8 million USD

Day Vol.

80619

Previous Day Vol.

119047

Currency

USD

Primary Exchange

Nasdaq

NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reu...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prnewswire - NLS Pharmaceutics Announces the Launch of a Preclinical Program for Mazindol ER in the Treatment of Fentanyl Dependence

NLS Pharmaceutics is launching a preclinical program to evaluate Mazindol ER as a potential treatment for fentanyl dependence, a major global health crisis. Mazindol ER targets multiple neurotransmitter systems implicated in opioid addiction, offering a non-opioid alternative.

Related tickers: NLSP, NLSPW, KMSTF.

Read Full Article

Prnewswire - Kadimastem Calls for a Special General Meeting of Shareholders to Approve the Merger with NLS

Kadimastem has called for a special general meeting of shareholders to approve the merger with NLS Pharmaceutics. The merger aims to create a combined Nasdaq-traded biotechnology company with a robust pipeline of advanced therapies.

Related tickers: NLSP, NLSPW, KMSTF.

Read Full Article

Trending Tickers

Please sign in to view